MolMed Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 223

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 1

MolMed General Information

Description

Molmed SpA is an Italy based medical biotechnology company. It is engaged in research, development and clinical validation of innovative therapies to treat cancer. The company's therapies include TK for blood cancers and NGR-hTNF for solid tumors. Its pipeline includes antitumor therapeutics in clinical and preclinical development.

Contact Information

Website
www.molmed.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Acquirer
Corporate Office
  • Via Olgettina 58
  • 20132 Milan
  • Italy
+39 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MolMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MolMed‘s full profile, request access.

Request a free trial

MolMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Molmed SpA is an Italy based medical biotechnology company. It is engaged in research, development and clinical validati
Biotechnology
Milan, Italy
223 As of 2020
00000
00000 0000-00-00
000000&0 00000

00000

ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000000000000
Cambridge, MA
000 As of 0000
00000
000000&0

000000

ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vo
0000 000000000
Rockville, MD
0 As of 0000
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MolMed Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agios Pharmaceuticals Formerly VC-backed Cambridge, MA 000 00000 000000&0
CytImmune Sciences Private Equity-Backed Rockville, MD 0 000.00 000000000000 000.00
You’re viewing 2 of 2 competitors. Get the full list »

MolMed Patents

MolMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-69916829-D1 Genetically modified fibroblasts and their use Inactive 08-May-1998 0000000000
EP-1084232-B1 Genetically-modified fibroblasts and the use thereof Inactive 08-May-1998 0000000000
EP-1084232-A1 Genetically-modified fibroblasts and the use thereof Active 08-May-1998 0000000000
DE-69632263-D1 Composition and method for giving the resistivity to hiv superinfection on cells Inactive 09-Oct-1995 0000000000
ES-2220994-T3 Composition and procedure to provide cell resistivity against hiv overinfections. Inactive 09-Oct-1995 C07K14/005
To view MolMed’s complete patent history, request access »

MolMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MolMed Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MolMed‘s full profile, request access.

Request a free trial

MolMed Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GenEra 01-Jan-2002 0000000000 Biotechnology
To view MolMed’s complete acquisitions history, request access »

MolMed FAQs

  • When was MolMed founded?

    MolMed was founded in 1996.

  • Who is the founder of MolMed?

    Claudio Bordignon MD is the founder of MolMed.

  • Where is MolMed headquartered?

    MolMed is headquartered in Milan, Italy.

  • What is the size of MolMed?

    MolMed has 223 total employees.

  • What industry is MolMed in?

    MolMed’s primary industry is Biotechnology.

  • Is MolMed a private or public company?

    MolMed is a Private company.

  • What is the current valuation of MolMed?

    The current valuation of MolMed is 00000.

  • What is MolMed’s current revenue?

    The current revenue for MolMed is 00000.

  • How much funding has MolMed raised over time?

    MolMed has raised $184M.

  • Who are MolMed’s investors?

    Delfin, EDCP venture capital, Finanziaria d'investimento Fininvest, H Equity Partners, and Intesa Sanpaolo are 5 of 7 investors who have invested in MolMed.

  • Who are MolMed’s competitors?

    Agios Pharmaceuticals and CytImmune Sciences are competitors of MolMed.

  • When was MolMed acquired?

    MolMed was acquired on 31-Jul-2020.

  • Who acquired MolMed?

    MolMed was acquired by AGC Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »